192 related articles for article (PubMed ID: 32715632)
1. Height after photon craniospinal irradiation in pediatric patients treated for central nervous system embryonal tumors.
Mizumoto M; Oshiro Y; Pan H; Wang F; Kaste SC; Gajjar A; Chemaitilly W; Merchant TE
Pediatr Blood Cancer; 2020 Oct; 67(10):e28617. PubMed ID: 32715632
[TBL] [Abstract][Full Text] [Related]
2. Clinical experience of craniospinal intensity-modulated spot-scanning proton therapy using large fields for central nervous system medulloblastomas and germ cell tumors in children, adolescents, and young adults.
Hashimoto T; Shimizu S; Takao S; Terasaka S; Iguchi A; Kobayashi H; Mori T; Yoshimura T; Matsuo Y; Tamura M; Matsuura T; Ito YM; Onimaru R; Shirato H
J Radiat Res; 2019 Jul; 60(4):527-537. PubMed ID: 31111946
[TBL] [Abstract][Full Text] [Related]
3. Necrosis after craniospinal irradiation: results from a prospective series of children with central nervous system embryonal tumors.
Murphy ES; Merchant TE; Wu S; Xiong X; Lukose R; Wright KD; Qaddoumi I; Armstrong GT; Broniscer A; Gajjar A
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e655-60. PubMed ID: 22768993
[TBL] [Abstract][Full Text] [Related]
4. Spinal changes after craniospinal irradiation in pediatric patients.
Oshiro Y; Mizumoto M; Pan H; Kaste SC; Gajjar A; Merchant TE
Pediatr Blood Cancer; 2020 Dec; 67(12):e28728. PubMed ID: 33009883
[TBL] [Abstract][Full Text] [Related]
5. Craniospinal irradiation prior to stem cell transplant for hematologic malignancies with CNS involvement: Effectiveness and toxicity after photon or proton treatment.
Gunther JR; Rahman AR; Dong W; Yehia ZA; Kebriaei P; Rondon G; Pinnix CC; Milgrom SA; Allen PK; Dabaja BS; Smith GL
Pract Radiat Oncol; 2017; 7(6):e401-e408. PubMed ID: 28666906
[TBL] [Abstract][Full Text] [Related]
6. Reduced-dose craniospinal irradiation for central nervous system relapsed neuroblastoma.
Luo LY; Kramer K; Cheung NV; Kushner BH; Modak S; Basu EM; Roberts SS; Wolden SL
Pediatr Blood Cancer; 2020 Sep; 67(9):e28364. PubMed ID: 32608559
[TBL] [Abstract][Full Text] [Related]
7. Endocrine outcomes for children with embryonal brain tumors after risk-adapted craniospinal and conformal primary-site irradiation and high-dose chemotherapy with stem-cell rescue on the SJMB-96 trial.
Laughton SJ; Merchant TE; Sklar CA; Kun LE; Fouladi M; Broniscer A; Morris EB; Sanders RP; Krasin MJ; Shelso J; Xiong Z; Wallace D; Gajjar A
J Clin Oncol; 2008 Mar; 26(7):1112-8. PubMed ID: 18309946
[TBL] [Abstract][Full Text] [Related]
8. A Multi-institutional Comparative Analysis of Proton and Photon Therapy-Induced Hematologic Toxicity in Patients With Medulloblastoma.
Liu KX; Ioakeim-Ioannidou M; Susko MS; Rao AD; Yeap BY; Snijders AM; Ladra MM; Vogel J; Zaslowe-Dude C; Marcus KJ; Yock TI; Grassberger C; Braunstein SE; Haas-Kogan DA; Terezakis SA; MacDonald SM
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):726-735. PubMed ID: 33243479
[TBL] [Abstract][Full Text] [Related]
9. Treatment outcomes and late toxicities in patients with embryonal central nervous system tumors.
Odagiri K; Omura M; Hata M; Aida N; Niwa T; Goto H; Ito S; Adachi M; Yoshida H; Yuki H; Inoue T
Radiat Oncol; 2014 Sep; 9():201. PubMed ID: 25209395
[TBL] [Abstract][Full Text] [Related]
10. Comparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient.
Zhang R; Howell RM; Giebeler A; Taddei PJ; Mahajan A; Newhauser WD
Phys Med Biol; 2013 Feb; 58(4):807-23. PubMed ID: 23322160
[TBL] [Abstract][Full Text] [Related]
11. Survival after chemotherapy and stem cell transplant followed by delayed craniospinal irradiation is comparable to upfront craniospinal irradiation in pediatric embryonal brain tumor patients.
Raleigh DR; Tomlin B; Buono BD; Roddy E; Sear K; Byer L; Felton E; Banerjee A; Torkildson J; Samuel D; Horn B; Braunstein SE; Haas-Kogan DA; Mueller S
J Neurooncol; 2017 Jan; 131(2):359-368. PubMed ID: 27778212
[TBL] [Abstract][Full Text] [Related]
12. Early outcomes and patterns of failure following proton therapy for nonmetastatic intracranial nongerminomatous germ cell tumors.
Mokhtech M; Rotondo RL; Bradley JA; Sandler ES; Nanda R; Logie N; Aldana PR; Morris CG; Indelicato DJ
Pediatr Blood Cancer; 2018 Jun; 65(6):e26997. PubMed ID: 29380526
[TBL] [Abstract][Full Text] [Related]
13. Treatment outcomes, growth height, and neuroendocrine functions in patients with intracranial germ cell tumors treated with chemoradiation therapy.
Odagiri K; Omura M; Hata M; Aida N; Niwa T; Ogino I; Kigasawa H; Ito S; Adachi M; Inoue T
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):632-8. PubMed ID: 22420962
[TBL] [Abstract][Full Text] [Related]
14. Hearing loss and intellectual outcome in children treated for embryonal brain tumors: Implications for young children treated with radiation sparing approaches.
Moxon-Emre I; Dahl C; Ramaswamy V; Bartels U; Tabori U; Huang A; Cushing SL; Papaioannou V; Laperriere N; Bouffet E; Mabbott DJ
Cancer Med; 2021 Oct; 10(20):7111-7125. PubMed ID: 34480430
[TBL] [Abstract][Full Text] [Related]
15. Craniospinal irradiation for CNS leukemia: rates of response and durability of CNS control.
Ebadi M; Morse M; Gooley T; Ermoian R; Halasz LM; Lo SS; Yang JT; Blau MH; Percival ME; Cassaday RD; Graber J; Taylor LP; Venur V; Tseng YD
J Neurooncol; 2024 Jan; 166(2):351-357. PubMed ID: 38244173
[TBL] [Abstract][Full Text] [Related]
16. Changes in Peripheral Blood Regulatory T Cells and IL-6 and IL-10 Levels Predict Response of Pediatric Medulloblastoma and Germ Cell Tumors With Residual or Disseminated Disease to Craniospinal Irradiation.
Song L; Wang S; Fang T; Qiu X; Wang X; Zhou X; Morse MA; Hobeika A; Wu W; Yang H; Ren J; Lyerly HK
Int J Radiat Oncol Biol Phys; 2021 Oct; 111(2):479-490. PubMed ID: 33974888
[TBL] [Abstract][Full Text] [Related]
17. Scoliosis in Children Treated With Photon Craniospinal Irradiation for Medulloblastoma.
Paulino AC; Suzawa HS; Dreyer ZE; Hanania AN; Chintagumpala M; Okcu MF
Int J Radiat Oncol Biol Phys; 2021 Mar; 109(3):712-717. PubMed ID: 33516438
[TBL] [Abstract][Full Text] [Related]
18. Genetic susceptibility to cognitive decline following craniospinal irradiation for pediatric central nervous system tumors.
Brown AL; Sok P; Raghubar KP; Lupo PJ; Richard MA; Morrison AC; Yang JJ; Stewart CF; Okcu MF; Chintagumpala MM; Gajjar A; Kahalley LS; Conklin H; Scheurer ME
Neuro Oncol; 2023 Sep; 25(9):1698-1708. PubMed ID: 37038335
[TBL] [Abstract][Full Text] [Related]
19. Final height and weight of long-term survivors of childhood malignancies.
Müller HL; Klinkhammer-Schalke M; Kühl J
Exp Clin Endocrinol Diabetes; 1998; 106(2):135-9. PubMed ID: 9628245
[TBL] [Abstract][Full Text] [Related]
20. Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma.
Merchant TE; Kiehna EN; Li C; Shukla H; Sengupta S; Xiong X; Gajjar A; Mulhern RK
Int J Radiat Oncol Biol Phys; 2006 May; 65(1):210-21. PubMed ID: 16472938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
